In less than 1% of FH cases, pathogenic variants are detected in the gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9), which participates in LDL-C upregulation in the blood, and clinically important mutations in this gene enhance its function. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.